paliperidone

Generic: paliperidone

Labeler: westminster pharmaceuticals, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name paliperidone
Generic Name paliperidone
Labeler westminster pharmaceuticals, llc
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

paliperidone 1.5 mg/1

Manufacturer
Westminster Pharmaceuticals, LLC

Identifiers & Regulatory

Product NDC 69367-432
Product ID 69367-432_d8f51603-fa70-430b-82af-38a0bb7d5f50
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA218755
Listing Expiration 2026-12-31
Marketing Start 2025-12-09

Pharmacologic Class

Established (EPC)
atypical antipsychotic [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 69367432
Hyphenated Format 69367-432

Supplemental Identifiers

RxCUI
672567 672569 672571 866103
UPC
0369367433303 0369367434300 0369367435307
UNII
838F01T721
NUI
N0000175430

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name paliperidone (source: ndc)
Generic Name paliperidone (source: ndc)
Application Number ANDA218755 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 1.5 mg/1
source: ndc
Packaging
  • 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (69367-432-30)
source: ndc

Packages (1)

69367-432-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (69367-432-30)

Ingredients (1)

paliperidone (1.5 mg/1)

Linked Drug Pages (1)

Paliperidone ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "d8f51603-fa70-430b-82af-38a0bb7d5f50", "openfda": {"nui": ["N0000175430"], "upc": ["0369367433303", "0369367434300", "0369367435307"], "unii": ["838F01T721"], "rxcui": ["672567", "672569", "672571", "866103"], "spl_set_id": ["1745a460-5e3a-4a1f-8eb3-64bb112f47a4"], "pharm_class_epc": ["Atypical Antipsychotic [EPC]"], "manufacturer_name": ["Westminster Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (69367-432-30)", "package_ndc": "69367-432-30", "marketing_start_date": "20251209"}], "brand_name": "Paliperidone", "product_id": "69367-432_d8f51603-fa70-430b-82af-38a0bb7d5f50", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Atypical Antipsychotic [EPC]"], "product_ndc": "69367-432", "generic_name": "Paliperidone", "labeler_name": "Westminster Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Paliperidone", "active_ingredients": [{"name": "PALIPERIDONE", "strength": "1.5 mg/1"}], "application_number": "ANDA218755", "marketing_category": "ANDA", "marketing_start_date": "20251209", "listing_expiration_date": "20261231"}